期刊文献+

炎症性肠病患者血清学抗体与临床表型的相关性研究

Correlative Study of Serum Antibodies and clinical phenotype of Inflammatory Bowel Disease
下载PDF
导出
摘要 目的探讨血清p-ANCA、ASCA、PAB和GAB与IBD临床表型的可能相关性。方法间接免疫荧光法检测32例溃疡性结肠炎(UC)、47例克罗恩病(CD)患者血清p-ANCA、ASCA、GAB和PAB的表达,用χ~2检验分析抗体与IBD临床表型的关系。结果诊断时年龄>40岁的CD患者p-ANCA阳性率高于≤40岁者(25.0%vs0.0%,P <0.05);穿透型、狭窄型、非狭窄非穿透型CD患者ASCA阳性率分别为60.0%、20.0%、9.1%(P <0.05);女性CD患者GAB阳性率高于男性(76.5%vs 40.0%,P <0.05)。未发现p-ANCA、ASCA、PAB、GAB与UC的临床表型、PAB与CD的临床表型有关。结论 ANCA阳性的CD患者起病时间晚,狭窄型或穿孔型CD患者ASCA阳性率较高,女性CD患者GAB阳性率较高,p-ANCA、ASCA、PAB、GAB与UC的临床表型无关。 Objective To study the possible correlation between serumal perinuclear anti-neutrophil cytoplasmic antibody(p-ANCA), anti-saccharomyces cerevisiae antibody(ASCA),anti-intestinal goblet cell antibody(GAB) and anti-pancreatic antibody(PAB) and the clinical phenotype of inflammatory bowel disease(IBD). Methods The serum levels of p-ANCA, ASCA, GAB and PAB in 32 patients with UC, 47 patients with CD were detected by indirect immunofluorescence assay. Pearson Chi-square test was employed for analyzing the correlations of these serum antibodies with IBD. Results The positive percentage of p-ANCA in CD patients 〉40 age at diagnosis was higher than that in CD patients≤40 age(25.0% vs 0.0%, P =0.026). The percentages of ASCA positivity were different among CD patients with internal penetrating(60.0%), with structuring(20.0%), and with non-penetrating non-stricturing behavior(9.1%, P =0.042). The positive-GAB rate in female CD patients was higher than in male(76.5% vs 40.0%, P =0.016). There was no statistically significant association between p-ANCA, ASCA, PAB or GAB and clinical feature in patients with UC, as well as PAB in CD patients. Conclusions The positive p-ANCA rate was relatively higher in senior patients. The percentage of positive-ASCA was higher in CD with internal stricturing or with penetrating behavior, as well as GAB in female CD patients. Expression of p-ANCA, ASCA, PAB and GAB was not associated with UC clinical phenotype.
作者 王玉萍 王承党 WANG Yu-ping;WANG Cheng-dang(Digestive Endoscopy Center,First Affiliated Hospital of Fujian Medical University,Fuzhou 350005,China;Digestive Disease Research Laboratory,Department of Gastroenterology,First Affiliated Hospital of Fujian Medical University,Fuzhou 350005,China)
出处 《中国医药指南》 2018年第25期4-5,7,共3页 Guide of China Medicine
关键词 炎症性肠病 溃疡性结肠炎 克罗恩病 血清学抗体 临床表型 Inflammatory bowel disease Ulcerative colitis Crohn's disease Serological antibody Clinical phenotype
  • 相关文献

参考文献2

二级参考文献18

  • 1HO GT,CHIAM P,DRUMMOND H,et al. The efficacy of corticosteroid therapy in inflammatory bowel disease:analysis of a 5-year UK inception cohort [ J ]. Aliment Pharmacol Ther,2006,24 : 319.
  • 2JARNEROT G, ROLNY P, SANDBERG-GERTZEN H. Intensive intravenous treatment of ulcerative colitis [ J ]. Gastroenterology, 1985, 89 : 1005
  • 3FAUBION WAJ, LOFTUS EVJ, HARMSEN WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study [ J ]. Gastroenterology,2001,121:255.
  • 4HO GT, MOWAT C, GODDARD C J, et al. Predicting the outcome of severe ulcerative colitis:development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery[ J ]. Aliment Pharmacol, Ther,2004,19 (10) : 1079.
  • 5ISRAELI E, GROTTO I, GILBURD B, et al. Anti-saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease[ J]. Gut,2005,54 : 1232.
  • 6SANDBORN WJ, LANDERS CJ,TREMAINE WJ,et al. Antin-eutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis[ J]. Am J Gastroenterol, 1995,90:740.
  • 7BANSI DS, CHAPMAN RW, FLEMING KA. Prevalance and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease [ J ]. Eur J Gastroenteml Hepatol, 1996,8:881.
  • 8FEAGAN B, RUTGEERTS P, SCHREIBER S, et al. Low baseline CRP correlates with high placebo remission rate in Crohn' s disease Clinical trials at 12 weeks[ J ]. Gastroenterology,2005,128 :A307.
  • 9ARDIZZONE S, MACONI G, RUSSO A, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis[ J]. Gut,2006,55:47.
  • 10中华医学会消化病学分会.我国炎症性肠病诊断与治疗的共识意见[J].内科理论与实践,2013,8(1):408-413.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部